UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

PharmacoEconomics, 2018-07, Vol.36 (7), p.809-822

2018

Volltextzugriff (PDF)

Case‐control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes

Epilepsia (Copenhagen), 2009-03, Vol.50 (3), p.493-500

2009

Volltextzugriff (PDF)

Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

PharmacoEconomics, 2018-07, Vol.36 (7), p.881-881

2018

Volltextzugriff (PDF)

Sa1066 Prevalence, Treatment, and Comorbidities of HCV Infection Among Patients With Commercial and Medicaid Insurance

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-987-S-988

2013

Volltextzugriff (PDF)

Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting

Epilepsy & behavior, 2009-10, Vol.16 (2), p.268-273

2009

Volltextzugriff (PDF)

Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics

The Annals of pharmacotherapy, 2007-10, Vol.41 (10), p.1593-1603

2007

Volltextzugriff (PDF)

NASH Diagnosis Is Associated With Disease States That Increase Risk of Endoscopy Complications: The Steatohepatitis Obesity Longitudinal Active Registry and Data Repository (SOLAR-DR): 894

The American journal of gastroenterology, 2017-10, Vol.112, p.S502-S503

2017

Volltextzugriff (PDF)

Survey of Clinician Beliefs Regarding the Screening and Diagnosis of Non-Alcoholic Steatohepatitis (NASH): 2868

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S1585-S1586

2018

Volltextzugriff (PDF)

Cost Benefit and Break-Even Analysis of Screening for Non-Alcoholic Fatty Liver Disease Utilizing FibroScan as Compared to Usual Care: 1011

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S568-S568

2018

Volltextzugriff (PDF)

1557. The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Volltextzugriff (PDF)

Relationship between direct-to-consumer advertising and physician diagnosing and prescribing

American journal of health-system pharmacy, 2002-01, Vol.59 (1), p.42-49

2002

Volltextzugriff (PDF)

Development of an interactive model of the burden of future coronary heart disease from an employer perspective

Journal of occupational and environmental medicine, 2010-09, Vol.52 (9), p.851-857

2010

Volltextzugriff (PDF)

Cardiovascular risk among HIV-positive subjects preceding exposure to HAART: a retrospective claims analysis

Future virology, 2013-09, Vol.8 (9), p.849-860

2013

Volltextzugriff (PDF)

Sa1554 – Fibroscan Risk Assessment of Non-Alcoholic Fatty Liver Disease (Fran Trial) in Endoscopy Centers Reveals Significant Undiagnosed Liver Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-350-S-351

2019

Volltextzugriff (PDF)

Sa1552 – Fibroscan Assessment of Patients Undergoing Endoscopy Reveals a High Prevalence of Liver Disorder

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-350-S-350

2019

Volltextzugriff (PDF)

Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018

Journal of managed care & specialty pharmacy, 2024-08, Vol.30 (8), p.817-824

2024

Volltextzugriff (PDF)

Persistence in treatment-experienced people with HIV switching anti-retroviral therapy regimens since 2018

Future virology, 2024-07, Vol.19 (10-11), p.371-380

2024

Volltextzugriff (PDF)

Sa1553 – Reliability and Validity Assessment If the Chronic Liver Disease Questionnaire Nafld-Nash in Patients with Nonalcoholic Fatty Liver Disease in the Community-Based Setting

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-350-S-350

2019

Volltextzugriff (PDF)

Treatment Patterns of Patients Receiving Simvastatin Monotherapy with Abnormalities in HDL-C and/or TG Levels

Journal of clinical lipidology, 2009, Vol.3 (3), p.232-232

2009

Volltextzugriff (PDF)

Angiotensin‐Converting Enzyme Inhibitor Therapy in Patients with Heart Failure Enrolled in a Managed Care Organization: Effect on Costs and Probability of Hospitalization

Pharmacotherapy, 2004-03, Vol.24 (3), p.351-357

2004

Volltextzugriff (PDF)

Barriers to access to care reported by women living with HIV across 27 countries

AIDS care, 2015-10, Vol.27 (10), p.1220-1230

2015

Volltextzugriff (PDF)

A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals

Clinical therapeutics, 2003, Vol.25 (1), p.309-329

2003

Volltextzugriff (PDF)

Clinicians' responses to direct-to-consumer advertising of prescription medications

Archives of internal medicine (1960), 2003-08, Vol.163 (15), p.1808

2003

Volltextzugriff (PDF)

Application of probabilistic sensitivity analysis in decision analytic modeling

Formulary (Cleveland, Ohio), 2002-01, Vol.37 (1), p.32

2002

Volltextzugriff (PDF)

Patient autonomy and the regulation of direct-to-consumer advertising

Clinical therapeutics, 2001-12, Vol.23 (12), p.2024-2037

2001

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(39)

Publikationsform

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

Case‐control analysis of ambulance, emergency room, or inpatient hospital events for epilepsy and antiepileptic drug formulation changes

Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin

Sa1066 Prevalence, Treatment, and Comorbidities of HCV Infection Among Patients With Commercial and Medicaid Insurance

Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting

Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics

NASH Diagnosis Is Associated With Disease States That Increase Risk of Endoscopy Complications: The Steatohepatitis Obesity Longitudinal Active Registry and Data Repository (SOLAR-DR): 894

Survey of Clinician Beliefs Regarding the Screening and Diagnosis of Non-Alcoholic Steatohepatitis (NASH): 2868

Cost Benefit and Break-Even Analysis of Screening for Non-Alcoholic Fatty Liver Disease Utilizing FibroScan as Compared to Usual Care: 1011

1557. The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US

Relationship between direct-to-consumer advertising and physician diagnosing and prescribing

Development of an interactive model of the burden of future coronary heart disease from an employer perspective

Cardiovascular risk among HIV-positive subjects preceding exposure to HAART: a retrospective claims analysis

Sa1554 – Fibroscan Risk Assessment of Non-Alcoholic Fatty Liver Disease (Fran Trial) in Endoscopy Centers Reveals Significant Undiagnosed Liver Disease

Sa1552 – Fibroscan Assessment of Patients Undergoing Endoscopy Reveals a High Prevalence of Liver Disorder

Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018

Persistence in treatment-experienced people with HIV switching anti-retroviral therapy regimens since 2018

Sa1553 – Reliability and Validity Assessment If the Chronic Liver Disease Questionnaire Nafld-Nash in Patients with Nonalcoholic Fatty Liver Disease in the Community-Based Setting

Treatment Patterns of Patients Receiving Simvastatin Monotherapy with Abnormalities in HDL-C and/or TG Levels

Angiotensin‐Converting Enzyme Inhibitor Therapy in Patients with Heart Failure Enrolled in a Managed Care Organization: Effect on Costs and Probability of Hospitalization

Barriers to access to care reported by women living with HIV across 27 countries

A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals

Clinicians' responses to direct-to-consumer advertising of prescription medications

Application of probabilistic sensitivity analysis in decision analytic modeling

Patient autonomy and the regulation of direct-to-consumer advertising

Suchergebnisse filtern